Skip to main content


Firm News

Mayer Brown advises Baxter International on $5 billion private placement by Baxalta spinoff

6 July 2015

Mayer Brown represented Baxter International Inc. on the financing of Baxalta Incorporated, the new public company spun off by Baxter on July 1, 2015 that holds the former biopharmaceuticals business of Baxter. The financing consisted of a Rule 144A/Regulation S offering of $5 billion of senior notes of Baxalta and the concurrent tender offer by Baxter for approximately $3 billion of its outstanding public debt. The transaction also involved establishing new domestic and international credit facilities for each of Baxter and Baxalta.

The Chicago-based Mayer Brown team was led by Corporate & Securities partner David Schuette and included Corporate & Securities associates Christine Shepard, James Lisak and Nicole Puza; Banking & Finance partner Rob Baptista and associate Jennifer Bruni; and Tax Transactions & Consulting partner James Barry.

Related Information

  • Related People
    David A. Schuette
    T +1 312 701 7363
    James R. Barry
    T +1 312 701 7169
    Christine M. McDevitt (Shepard)
    T +1 312 701 8583
    Jennifer L. Bruni
    T +1 312 701 7490
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.